8th Annual Biosimilars Asia

About the conference
 
At IBC Asia’s 8th Annual Biosimilars Asia, top industry players will come together to explore strategies for maneuvering the regulatory environment in China, better optimising R&D capabilities, and overcoming hurdles unique to biosimilars in China.

In addition, focus will be on integrating capabilities and building symbiotic partnerships in an increasingly globalised industry, and how to further enhance pre-clinical and clinical studies for better demonstration of similarity in a highly competitive market. The event will also expound on the opportunities and challenges unique to biosimilars in China and latest insights into patient safety and immunogenicity.

Why you must attend!
•Unparalleled learning and targeted networking across three (3) co-located events
•Asia’s leading and most highly-anticipated Biosimilars meeting
•The only biosimilars conference that highlights case studies on market access and commercialisation
•The region’s largest gathering of leading and future stakeholders across the industry
•Hear from top industry players as they discuss and explore strategies for ensuring patient safety, immunogenicity matters and risk management.
•Learn from case studies on how to better optimize development strategies and production capabilities to ensure high product quality and stay ahead of competition